Tag: avadel pharmaceuticals
November 25, 2019
Avadel Pharma Reaches Enrollment Target in REST-ON Trial
The company announced that its Phase 3 REST-ON Phase 3 trial has enrolled 205 patients who have narcolepsy and cataplexy,... May 22, 2019
Avadel Pharmaceuticals Receives FDA Acceptance for New Drug Application
Avadel Pharmaceuticals (NASDAQ:AVDL) has announced that the US Food and Drug Administration (FDA) has granted the company new drug application... November 5, 2018
Avadel Pharmaceuticals Reports Third Quarter 2018 Financial Results
Avadel Pharmaceuticals (NASDAQ:AVDL) has announced its financial results for Q3 2018. As quoted in the press release: Mike Anderson, Avadel’s...
October 7, 2018
5 Top Weekly NASDAQ Biotech Stocks: vTv Leads with 374 Percent
vTv Therapeutics, Trevena, Cyclacel Pharmaceuticals, Paratek Pharmaceuticals and Avadel Pharmaceuticals were last week's top gainers on the NASDAQ Biotechnology Index. September 28, 2018
